Get the Stockscreener App
31.76
2.84%
-0.93
After Hours:
31.54
-0.22
-0.69%
Harrow Inc stock is traded at $31.76, with a volume of 504.96K.
It is down -2.84% in the last 24 hours and up +3.99% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
See More
Previous Close:
$32.69
Open:
$32.64
24h Volume:
504.96K
Relative Volume:
1.14
Market Cap:
$1.17B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-33.08
EPS:
-0.96
Net Cash Flow:
$-20.74M
1W Performance:
-14.70%
1M Performance:
+3.99%
6M Performance:
+3.39%
1Y Performance:
+23.20%
1-Day Range:
$31.26
$33.22
1-Week Range:
$31.26
$37.51
52-Week Range:
$20.85
$59.23
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
1A BURTON HILLS BLVD, NASHVILLE, CA
Compare HROW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
31.76 | 1.20B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-12-25 | Initiated | BTIG Research | Buy |
| Jun-10-25 | Initiated | William Blair | Outperform |
| Feb-06-25 | Initiated | H.C. Wainwright | Buy |
| Dec-04-24 | Reiterated | B. Riley Securities | Buy |
| Apr-11-24 | Initiated | Craig Hallum | Buy |
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
View All
Harrow Inc Stock (HROW) Latest News
What are Harrow Inc. company’s key revenue driversMarket Forecast Recommendation With Low Risk - jammulinksnews.com
What are the technical indicators suggesting about Harrow Inc.AI Powered Strategy For 2025 - jammulinksnews.com
What Fibonacci levels say about Harrow Inc. reboundTrade Timing Strategy With Technical Data Explained - metal.it
Candlestick Reversal Detected on Harrow Inc.’s ChartSwing Setup With Technical Confirmation Explained - metal.it
What is the risk reward ratio of investing in Harrow Inc. stockFree Stock Target Finder That Work - jammulinksnews.com
Institutional owners may ignore Harrow, Inc.'s (NASDAQ:HROW) recent US$81m market cap decline as longer-term profits stay in the green - simplywall.st
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 - GlobeNewswire
Leading Eyecare Pharma Harrow Sets Q2 Earnings Release: Key Details for Investors - Stock Titan
Why Harrow Inc. stock attracts strong analyst attentionDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
Published on: 2025-07-28 19:53:29 - metal.it
How volatile is Harrow Inc. stock compared to the marketWealth Building Watchlist For Every Investor - jammulinksnews.com
How does Harrow Inc. generate profit in a changing economyInvest confidently with daily market forecasts - jammulinksnews.com
What is the dividend policy of Harrow Inc. stockAchieve consistent double-digit returns - jammulinksnews.com
Why Harrow Inc. stock is on top investor watchlistsCarefully Curated High Return Stocks - beatles.ru
What are analysts’ price targets for Harrow Inc. in the next 12 monthsStrong return on assets - jammulinksnews.com
What catalysts could drive Harrow Inc. stock higher in 2025Dynamic investment opportunities - jammulinksnews.com
What makes Harrow Inc. stock price move sharplyControlled Risk High Reward Plan - metal.it
Is it the right time to buy Harrow Inc. stockUnlock expert stock analysis and alerts - jammulinksnews.com
What are the latest earnings results for Harrow Inc.Fastest-growing stock picks - jammulinksnews.com
Does Harrow Inc. stock perform well during market downturnsGet timely alerts on market movers - jammulinksnews.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc.HROW - WV News
Harrow, Inc. (HROW): A Bull Case Theory - MSN
Harrow Inc. Stock Analysis and ForecastExplosive wealth accumulation - PrintWeekIndia
What drives Harrow Inc. stock priceFree Technical Analysis Support - PrintWeekIndia
What analysts say about Harrow Inc. stockFree Stock Market Trend Analysis - Autocar Professional
Is Harrow Inc. a good long term investmentRapid capital growth - jammulinksnews.com
Harrow jumps as Cantor initiates with Bullish view on conservative outlook - MSN
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):